According to the article, Duloxetine Delayed-Release Capsules were recently recalled due to the presence of N-nitroso-duloxetine. The recalled medication was manufactured by Towa Pharmaceutical in Europe and distributed nationwide in the United States. 7,100 bottles were recalled so far. The amount of N-nitroso-duloxetine was above the proposed interim limit(600 ng/day) and FDA set risk as Class II.